Fighting Mortality in the Waiting List: Liver Transplantation in North America, Europe, and Asia
Overview
Affiliations
Liver disease is a major cause of mortality worldwide. Liver transplantation (LT) is the most effective treatment for end stage liver disease. Available resources and social circumstances have led to different ways of implementing LT around the world. The experience with pediatric LT corroborates the hypothesis that a combination of surgical strategies can be beneficial. The goal of this manuscript is to describe the strategies used by LT centers in North America, Europe and Asia and how these strategies can be applied to reduce waitlist mortality and increase access to LT.
Dhayanithy G, Radhakrishnan S, Ann Martin C, Caroline Martin J, Hakeem A, Jothimani D Clin Exp Immunol. 2025; 219(1).
PMID: 39973343 PMC: 11878573. DOI: 10.1093/cei/uxae125.
Tian Y, Jin M, Ye N, Gao Z, Jiang Y, Yan S Stem Cell Res Ther. 2025; 16(1):57.
PMID: 39920844 PMC: 11806715. DOI: 10.1186/s13287-025-04169-w.
Trends of liver transplantation in Asia.
Pang N, Chan A, Kow A Updates Surg. 2024; .
PMID: 39046632 DOI: 10.1007/s13304-024-01924-1.
The transformative potential of artificial intelligence in solid organ transplantation.
Moussawy M, Lakkis Z, Ansari Z, Cherukuri A, Abou-Daya K Front Transplant. 2024; 3:1361491.
PMID: 38993779 PMC: 11235281. DOI: 10.3389/frtra.2024.1361491.
Mir T, Alzhrani A, Nakamura M, Iwanaga S, Wani S, Altuhami A Bioengineering (Basel). 2023; 10(10).
PMID: 37892856 PMC: 10604736. DOI: 10.3390/bioengineering10101126.